Homologous and heterologous serological response to the N-terminal domain of SARS-CoV-2
H. Lv, O. T.-Y. Tsang, R. T. Y. So…·C. K. P. Mok
The paper examines the serological response to the N-terminal domain (NTD) of SARS-CoV-2, showing it is less cross-reactive with SARS-CoV and less effective as an immunogen compared to the RBD.